Challenges and opportunities of antibacterial drug discovery
Bolin Geng
Targeting cancer stem cells: Challenges and opportunities
Xiaoyan Jiang
Potential Neurotoxic Effects of Anesthetics during Development and Potential Protective Agents
Cheng Wang
Dongzhou J. Liu
New drug screening strategy for infectious diseases: The power of common sense
Maryse Picher
FU Xiao zhong, JIANG Sai hong, YANG Yu she and JI Ru yun
Ahmed A. Aboelwafa and Amal Ibrahim
Turkey disposal and recycling for drug industry
Ayse BAYRAK
Viral ion channels in drug discovery
Wolfgang B. Fischer
The potential economic impact of Biosimilars in the United States
Joseph P. Fuhr Jr
5-Cholesten-3beta, 25- diol 3-sulfate Serves as a New Medicine for Therapy of Hyperlipidemia
Shunlin Ren
Translating cellular science into human outcomes: A decade of experience with BCSbased biowaivers
Sid Bhoopathy
Bioequivalence of highly variable drugs across countries
Laszlo Endrenyi, Laszlo Tothfalusi
Qualitiy from analytics and the strategy behind the physiochemical characterisation of biomolecules
Ashleigh Wake
Detection of autosomal polycystic kidney disease using NMR spectroscopy
Wolfram Gronwald, Matthias S. Klein, Raoul Zeltner , Bernd-Detlef Schulze, Stephan W. Reinhold, Markus Deutschmann, Ann-Kathrin Immervoll, Carsten A. B?ger, Bernhard Banas, Kai- Uwe Eckardt and Peter J. Oefner
Paul Rainville1, Michael Tomany, James Murphy, Norman Smith, Joanne Mather and Robert Plumb
An efficient kinase assay and a rapid screening of kinase inhibitors based on a biochip
Sang Hyun Park, Mi Hee Choi, Jung Ae Kang, and Jong Kook Rho
Quantitative evaluation of Bioequivalence/ Biosimilarity
Shein-Chung Chow
The role of pharmacokinetic studies in development of drugs, containing endogenous compounds
Oleg Medvedev, Elena Kalenikova, Eugenia Gorodetskaya, Alexander Ivanov, Ekaterina Charitonova
Christian Joukhadar
Recent trends in antihypertensives based on their pharmacokinetic parameters
Sanjita Das
Valentina Echeverria
Glipizide pharmacokinetics in healthy and diabetic volunteers
Muhammad Atif, Syed Azhar Syed Sulaiman, Asrul Akmal Shafi e
Maricela Mart?nez
Bioavailability & Bioequivalence: Pharmacokinetic principles
Abdus Samad
Novel approaches of bioavailability and bioequivalence studies
Barbara M. Davit
Chyung S. Cook
Glycerophosphate does not interact with components of parenteral nutrition
Heinrich Topp, Olena Hochfeld, Staffan Bark, Matthias Grossmann, Christian Joukhadar, Martin Westphal, Harald Straatsma, Markus Rothenburger
Bioavailability study of zolmitriptan sublingual tablets on sheep model
Ziya BAYRAK, Cetin TAS, Umut TASDEMIR, Halil EROL, Cansel KOSE OZKAN, Ayhan SAVASER and Yalcin OZKAN
Modulation of bioavailability of anticancer drugs by Drug interactions: An update
Sanjita Das
The role of modeling and simulations to better understand, optimize and predict Bioequivalence
Murray P. Ducharme
Dissolution testing for generic drugs: An FDA perspective
Om Anand
Seongil Choi
Harmonizing best practices in bioanalytical methods
Maha Tutunj
Pre-clinical strategies to predict the Bioavailability/ Bioequivalence studies
Jos?lia Larger Manfio
Muzaffar Iqbal, and Lakhvinder Singh Batolar
Evaluation of the infl uence of obesity on the oral pharmacokinetics of Oseltamivir
Miriam del C. Carrasco-Portugal, Adrian Martinez Talavera, Lina M. Barranco-Gardu?o, Ariadna Cervantes- Nevarez, Juan C. Neri, Gilberto Casta?eda-Hern?ndez and Francisco J. Flores-Murrieta
GRAS Combinations to Alleviate Presystemic Metabolism
Phillip M. Gerk
Overview of submission of summary Bioequivalence data for ANDAs
Ethan Stier
Bioanalytical laboratory design; critical planning for 21st century bioequivalence laboratory
Naser L. Rezk
Novel approach for the targeting of acidic tissue: pHLIP ? pH (Low) Insertion Peptide
Oleg A. Andreev, Donald M. Engelman and Yana K. Reshetnyak
Scaled Average Bioequivalence Statistics for the Non-Statistician
Charles Bon
Batoul Sadat Haerian, Kheng Seang Lim, Hui Jan Tan, Chee Piau Wong, Sau Wei Wong, Chong Tin Tan, Azman Ali Raymond, Patrick Kwan, Larry Baum, Junji Saruwatari, Kazuko Nakagawa and Zahurin Mohamed
Noha Mohamed Zaki
Bioequivalency study for inhaled drugs: a pharmacodynamic approache
Luciana Fernandes Duarte, Eduardo Abib Junior
Current global challenges in the Bioequivalence of CR/MR and Multiphasic formulations of drugs
Murray P. Ducharme
Design and evaluation of polymeric ocular drug delivery system
Vrushali Kashikar, Indrajeet Gonjari and K. Jayveera
Natalia Fabbri, Eduardo Abib- Jr, Bruna Sharlac Vian, Antonio Amarante and Ricardo L Zollner
An anthology of various strategies to overcome the barriers of oral bioavailability
Kanchan Kohli
Vesicular systems for intranasal drug delivery
Ibrahim A. Alsarra, Amel Y. Hamed, Fars K. Alanazi and Gama M. E Maghraby
Lin Lei, Luo Baojun, Wu Xiaoyan, Li Jing Hu Yi, Luo yanjun, Zhu Qingyu and Chang Guohui
Mimovirus: a novel form of vaccine induced specifi c cytotoxic T lymphocyte responses in vivo
Yu-Zhang Wu
Nanosuspensions: An Enhanced Bioavailability of Pulmonary Drug Delivery
K. Vijaya Sri
Francisco E. Estevez-Carrizo